Patents by Inventor Maxime Robin

Maxime Robin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • AURONE DERIVATIVES AND USES THEREOF FOR CONTROLLING BACTERIA AND/OR FUNGI
    Publication number: 20230295103
    Abstract: The present invention relates to aurones compounds of formula (I) and their uses for controlling a bacterium and/or a fungus. The invention also relates to the use of such compounds as phytoprotective and/or decontaminating and/or disinfectant agent and compositions comprising them.
    Type: Application
    Filed: July 8, 2021
    Publication date: September 21, 2023
    Inventors: MAXIME ROBIN, MARC MARESCA, HAMZA OLLEIK, VALÉRIE PIQUE, JOSETTE PERRIER-VIRET, JEAN-MICHEL BOLLA, FABIENNE NEULAT-RIPOLL
  • DEVICE FOR MONITORING THE PRESSURE OR ALTERNATIVELY AN INJECTION FORCE OF A PLURALITY OF JETS GENERATED AT THE OUTLET OF A NEEDLELESS INJECTION DEVICE
    Publication number: 20210353864
    Abstract: A monitoring device for monitoring a pressure or an injection force of a plurality of jets generated by channels at an outlet of a nozzle of a needleless injection device. The monitoring device includes a plurality of measuring elements. Each measuring element is configured to measure a pressure or an injection force of a corresponding jet of the plurality of jets. Each measuring element includes a receiving face oriented to receive the corresponding jet.
    Type: Application
    Filed: August 2, 2021
    Publication date: November 18, 2021
    Applicant: CROSSJECT
    Inventors: Christophe AURIEL, Ludovic JAUMARY, Maxime ROBIN, Brice SIMONNEAU
  • Acridines As Inhibitors Of Haspin And DYRK Kinases
    Publication number: 20130102627
    Abstract: The present disclosure is directed to compounds of Formula I: which are inhibitors of Haspin kinase and DYRK kinases. The compounds of the present disclosure, and compositions thereof, are useful in the treatment of disease related to Haspin kinase and DYRK kinase expression and/or activity.
    Type: Application
    Filed: April 8, 2011
    Publication date: April 25, 2013
    Applicant: THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
    Inventors: Jonathan Higgins, Gregory D. Cuny, Marcie Glicksman, Debasis Patnaik, Maxime Robin, Ross L. Stein, Jun Xian